Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder

World Journal of Urology

Volumn 33, Issue 11, 2015, Pages 1753-1761

  Novotny, Vladimir ^a   Froehner, Michael ^a   May, Matthias ^b   Protzel, Chris ^c   Hergenröther, Katrin ^c   Rink, Michael ^d   Chun, Felix K ^d   Fisch, Margit ^d   Roghmann, Florian ^e   Palisaar, Rein Jüri ^e   Noldus, Joachim ^e   Gierth, Michael ^f   Fritsche, Hans Martin ^f   Burger, Maximilian ^f   Sikic, Danijel ^g   Keck, Bastian ^g   Wullich, Bernd ^g   Nuhn, Philipp ^h   Buchner, Alexander ^h   Stief, Christian G ^h   Vallo, Stefan ⁱ   Bartsch, Georg ⁱ   Haferkamp, Axel ⁱ   Bastian, Patrick J ^j   Hakenberg, Oliver W ^c   Propping, Stefan ^a   Aziz, Atiqullah ^d   more..

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b Urologische Klinik   (Germany)

^c University Medical Center Rostock   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f UNIVERSITY OF REGENSBURG   (Germany)

^g UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ GOETHE UNIVERSITY   (Germany)

^j Golzheim Paracelsus Clinic   (Germany)

more..

Author keywords

Bladder cancer; Outcome; Radical cystectomy; Recurrence

Indexed keywords

AGED; CANCER STAGING; CARCINOMA, TRANSITIONAL CELL; CLINICAL TRIAL; CYSTECTOMY; FOLLOW UP; GERMANY; HISTORY; HUMAN; INCIDENCE; MALE; MULTICENTER STUDY; POSTOPERATIVE PERIOD; PROCEDURES; PROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TIME FACTOR; TRENDS; TUMOR RECURRENCE; URINARY BLADDER NEOPLASMS;

AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FOLLOW-UP STUDIES; GERMANY; HISTORY, ANCIENT; HUMANS; INCIDENCE; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84945495202     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-015-1502-y     Document Type: Article

References (30)

1. Herr HW, Faulkner JR, Grossman HB et al (2004) Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 22:2781–2789
2. Rink M, Lee DJ, Kent M et al (2013) Predictors of cancer-specific mortality after disease recurrence following radical cystectomy. BJU Int 111(3 Pt B):E30–E36
3. Christodouleas JP, Baumann BC, He J et al (2014) Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710. Cancer 120(8):1272–1280
4. Froehner M, Novotny V, Wirth MP, et al (2014) External validation of a model to predict locoregional failure after radical cystectomy. Cancer. doi:10.1002/cncr.28876. [Epub ahead of print]
5. Aziz A, May M, Burger M et al (2014) Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol 66(1):156–163
6. Greene FL, Gospodarowicz M, Wittekend C et al (2009) American Joint Committee on Cancer (AJCC) staging manual, 7th edn. Springer, Philadelphia
7. Quek ML, Stein JP, Nichols PW et al (2005) Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol 174:103–106
8. Stenzl A, Cowan NC, De Santis M et al (2011) Treatment of muscleinvasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 59:1009–1018
9. Rink M, Fajkovic H, Cha EK et al (2012) Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 61:854–855
10. Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–504
11. May M, Bastian PJ, Brookman-May S et al (2013) Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. Urol Oncol 31:1141–1147
12. Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387
13. Visser O, Nieuwenhuijzen JA, Horenblas S (2005) Local recurrence after cystectomy and survival of patients with bladder cancer: a population based study in greater Amsterdam. J Urol 174:97–102
14. Volkmer BG, Kuefer R, Bartsch GC Jr et al (2009) Oncological followup after radical cystectomy for bladder cancer—is there any benefit? J Urol 181:1587–1593
15. Honma I, Masumori N, Sato E et al (2004) Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors. Urology 64(4):744–748
16. Hassan JM, Cookson MS, Smith JA Jr et al (2006) Patterns of initial transitional cell recurrence in patients after cystectomy. J Urol 175:2054–2057
17. Pollack A, Zagars GK, Cole CJ et al (1995) The relationship of local control to distant metastasis in muscle invasive bladder cancer. J Urol 154:2059–2063
18. Ide H, Kikuchi E, Miyajima A et al (2008) The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer. Jpn J Clin Oncol 38:360–364
19. Baumann BC, Guzzo TJ, He J et al (2013) A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy. Int J Radiat Oncol Biol Phys 85:81–88
20. Skinner EC, Stein JP, Skinner DG (2007) Surgical benchmarks for the treatment of invasive bladder cancer. Urol Oncol 25:66–71
21. May M, Herrmann E, Bolenz C et al (2011) Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. Ann Surg Oncol 18(7):2018–2025
22. Herr H, Lee C, Chang S et al (2004) Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. J Urol 171:1823–1828
23. Novara G, Svatek RS, Karakiewicz PI et al (2010) Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J Urol 183(6):2165–2170
24. Xylinas E, Rink M, Novara G et al (2013) Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy. Ann Surg Oncol 20(3):1027–1034
25. Lotan Y, Gupta A, Shariat SF et al (2005) Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23:6533–6539
26. Shariat SF, Svatek RS, Tilki D et al (2010) International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 105(10):1402–1412
27. Nakagawa T, Hara T, Kawahara T et al (2013) Prognostic risk stratification of patients with urothelial carcinoma of the bladder with recurrence after radical cystectomy. J Urol 189:1275–1281
28. Meeks JJ, Bellmunt J, Bochner BH et al (2012) A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol 62(3):523–533
29. Booth CM, Siemens DR, Li G et al (2014) Perioperative chemotherapy for muscle-invasive bladder cancer: a population-based outcomes study. Cancer 120(11):1630–1638
30. Burger M, Mulders P, Witjes W (2012) Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire. Eur Urol 61(5):1070–1071